VP, HTA and Market Access Policy - Johnson & Johnson
Will the future EU HTA cooperation respond to countries' needs and impact access to medical technologies?
Wednesday 15 May 10:40 - 11:30
Adrian Griffin is Vice President, HTA & Reimbursment Policy at Johnson & Johnson. He has been involved in the fields of health economics, outcomes research, and reimbursement policy within the healthcare industry for over 20 years, with experience across the pharmaceutical, medical device, and diagnostic sectors. Adrian currently serves on one of the NICE Technology Appraisal Committees, and was on the Board of Directors for ISPOR (the International Society for Pharmacoeconomics and Outcomes Research), between 2013-15.